Non-alcoholic fatty liver disease in obese subjects as related to increasing insulin resistance and deteriorating glucose control: Three years of follow-up from a longitudinal survey.

Autor: Forst T; CRS Clinical Research Services Mannheim GmbH, Grenadierstrasse 1, 68167 Mannheim, Germany., Botz I; CRS Clinical Research Services Mannheim GmbH, Grenadierstrasse 1, 68167 Mannheim, Germany., Berse M; CRS Clinical Research Services Berlin GmbH, Berlin, Germany., Voswinkel S; MLM Laboratories Mönchengladbach, Mönchengladbach, Germany., Strempler ME; CRS Clinical Research Services Berlin GmbH, Berlin, Germany., Baumann S; CRS Clinical Research Services Berlin GmbH, Berlin, Germany., Marinez M; CRS Clinical Research Services Mannheim GmbH, Grenadierstrasse 1, 68167 Mannheim, Germany.
Jazyk: angličtina
Zdroj: Journal of diabetes and metabolic disorders [J Diabetes Metab Disord] 2023 Dec 30; Vol. 23 (1), pp. 999-1006. Date of Electronic Publication: 2023 Dec 30 (Print Publication: 2024).
DOI: 10.1007/s40200-023-01378-z
Abstrakt: Purpose: This observational trial was performed to evaluate liver parameters in overweight or obese subjects in the context of insulin resistance and glucose control over time.
Subjects/methods: Insulin resistance, glucose control and several parameters for liver integrity were monitored in 177 overweight (BMI > 28 kg/m2) subjects over a mean of 30 months. Volunteers were categorized according to insulin resistance (HOMA IR score) and glucose control in subjects with normal glucose control (NGT), impaired glucose control (IGT), or diabetes mellitus type 2 (T2DM). Liver fat and fibrosis were evaluated by sonographic elastography (FibroScan®) and clinical scores, such as the AST/ALT ratio, fatty liver index (FLI), and NAFLD fibrosis score (NFS).
Results: Liver fat fraction as estimated by the controlled attenuation parameter (CAP), and the FLI were significantly higher in subjects with T2DM compared to IGT and NGT. While fasting insulin levels and the HOMA IR score continuously increased over time, no change in CAP or FLI occurred during follow up. CAP was correlated with FLI ( r  = 0.50; p  < 0.0001) and the HOMA IR score ( r  = 0.32; p  < 0.0001). An inverse correlation was observed between serum adiponectin levels and FLI ( r  = -0.37; p  < 0.0001), the HOMA IR score ( r  = -0.19; p  < 0.001, and CAP ( r  = -0.15; p  < 0.01).
Conclusions: In subjects with a BMI ≥ 28 kg/m 2 , liver fat fraction is significantly elevated in those with T2DM compared to IGT or NGT. Liver fat fraction is associated with deteriorating insulin sensitivity and loss of glucose control. Despite a continuous increase in insulin resistance, no change in liver fat content or stiffness occurred over 30 months.
Competing Interests: Conflict of interestThe authors declare no conflicts of interest regarding the contents of the manuscript.
(© The Author(s) 2023.)
Databáze: MEDLINE
Externí odkaz: